The National Marrow Donor Program 20 years of unrelated donor hematopoietic cell transplantation

被引:65
作者
Ballen, Karen K. [1 ]
King, Roberta J. [2 ]
Chitphakdithai, Pintip [2 ]
Bolan, Charles D., Jr. [3 ]
Agura, Edward [4 ]
Hartzman, Robert J. [5 ]
Kernan, Nancy A. [6 ]
机构
[1] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA
[2] Natl Marrow Donor Program, Minneapolis, MN USA
[3] NHLBI, Hematol Branch, NIH, Rockville, MD USA
[4] Baylor Univ, Med Ctr, Houston, TX 77030 USA
[5] USN, Med Res Ctr, CW Bill Young Dept, Def Marrow Donor Program, Rockville, MD USA
[6] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
National Marrow Donor Program; NMDP; unrelated donor; stem cell transplant; transplantation;
D O I
10.1016/j.bbmt.2008.05.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the 20 years since the National Marrow Donor Program (NMDP) facilitated the first unrelated donor transplant, the organization has grown to include almost 7 million donors, and has facilitated over 30,000 transplants on 6 continents. This remarkable accomplishment has been facilitated by the efforts of over 600 employees, and an extensive international network including 171 transplant centers, 73 donor centers, 24 cord blood banks, 97 bone marrow collection centers, 91 apheresis centers, 26 HLA typing laboratories, and 26 Cooperative Registries. In this article, we review the history of the NMDP, and cite the major trends in patient demographics, graft sources, and conditioning regimens over the last 20 years. (C) 2008 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:2 / 7
页数:6
相关论文
共 16 条
  • [1] Age and acute myeloid leukemia
    Appelbaum, FR
    Gundacker, H
    Head, DR
    Slovak, ML
    Willman, CL
    Godwin, JE
    Anderson, JE
    Petersdorf, SH
    [J]. BLOOD, 2006, 107 (09) : 3481 - 3485
  • [2] Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients
    Bacigalupo, A
    Bruno, B
    Saracco, P
    Di Bona, E
    Locasciulli, A
    Locatelli, F
    Gabbas, A
    Dufour, C
    Arcese, W
    Testi, G
    Broccia, G
    Carotenuto, M
    Coser, P
    Barbui, T
    Leoni, P
    Ferster, A
    [J]. BLOOD, 2000, 95 (06) : 1931 - 1934
  • [3] Impact of ethnicity and socioeconomic status on outcome of unrelated donor (URD) hematopoietic cell transplantation (HcT)
    Baker, K. Scoff
    Hassebroek, Anna
    Ballen, Karen
    Bigelow, Carolyn
    Frangoul, Haydar
    Hardy, Cheryl
    Lee, Stephanie
    Switzer, Galen
    Rizzo, J. Douglas
    Klein, John P.
    Majhail, Navneet
    Davies, Stella
    [J]. BLOOD, 2007, 110 (11) : 901A - 901A
  • [4] Outcome of unrelated transplants in patients with multiple myeloma
    Ballen, KK
    King, R
    Carston, M
    Kollman, C
    Nelson, G
    Lim, S
    Reece, D
    Giralt, S
    Vesole, DH
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 (07) : 675 - 681
  • [5] Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
    Childs, R
    Chernoff, A
    Contentin, N
    Bahceci, E
    Schrump, D
    Leitman, S
    Read, EJ
    Tisdale, J
    Dunbar, C
    Linehan, WM
    Young, NS
    Barrett, AJ
    Clave, E
    Epperson, D
    Mayo, V
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (11) : 750 - 758
  • [6] Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants
    Daly, A
    McAfee, S
    Dey, B
    Colby, C
    Schulte, L
    Yeap, B
    Sackstein, R
    Tarbell, NJ
    Sachs, D
    Sykes, M
    Spitzer, TR
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (06) : 373 - 382
  • [7] Deeg H J, 1999, Biol Blood Marrow Transplant, V5, P243, DOI 10.1053/bbmt.1999.v5.pm10465104
  • [8] Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation
    Dey, BR
    McAfee, S
    Sackstein, R
    Colby, C
    Saidman, S
    Weymouth, D
    Poliquin, C
    Vanderklish, J
    Sachs, DH
    Sykes, M
    Spitzer, TR
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (11) : 604 - 612
  • [9] TREATMENT OF APLASTIC-ANEMIA WITH ANTILYMPHOCYTE GLOBULIN AND METHYLPREDNISOLONE WITH OR WITHOUT CYCLOSPORINE
    FRICKHOFEN, N
    KALTWASSER, JP
    SCHREZENMEIER, H
    RAGHAVACHAR, A
    VOGT, HG
    HERRMANN, F
    FREUND, M
    MEUSERS, P
    SALAMA, A
    HEIMPEL, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) : 1297 - 1304
  • [10] Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: Long-term follow-up of the first 285 reported to the National Marrow Donor Program
    Giralt, Sergio
    Logan, Brent
    Rizzo, Douglas
    Zhang, Mei-Je
    Ballen, Karen
    Emmanouilides, Christos
    Nath, Rajneesh
    Parker, Pablo
    Porter, David
    Sandmaier, Brenda
    Waller, Edmund K.
    Barker, Juliet
    Pavletic, Steven
    Weisdorf, Daniel
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (07) : 844 - 852